Anna Bosch

Abstract CT103: Ciltacabtagene autoleucel in high-risk smoldering myeloma: Results from the CAR-PRISM trial

Omar Nadeem, David Cordas dos Santos, Sarah Nikiforow, Kevin DeBraganca et autres

us (code pays fourni par la source)

Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial

Omar Nadeem, David M. Cordas dos Santos, Sarah Nikiforow, Anna Bosch et autres

us, es (code pays fourni par la source)

Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML

Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock, Anna Bosch et autres

us (code pays fourni par la source)

Single-cell immune profiling reveals enhanced immune fitness of endogenous and engineered T cells in patients with high-risk smoldering myeloma compared to Relapsed/Refractory myeloma following bispecific antibodies or CAR-T cell therapies.

Francesco Corrado, Nayda Bidikian, Anna Bosch, Yoshinobu Konishi et autres

us (code pays fourni par la source)

O4 Development and validation of dimethylarginines (DAS) as a novel biomarker to identify pre-ACLF and predict outcomes following acute decompensation of cirrhosis in two prospective multicentre European cohorts

Kohilan Gananandan, Peter Holland‐Fischer, Karen Louise Thomsen, Konstantin Kazankov et autres

gb, dk, au, es, it, be, de (code pays fourni par la source)

Early Safety and Efficacy of CAR-T Cell Therapy in Precursor Myeloma: Results of the CAR-PRISM Study Using Ciltacabtagene Autoleucel in High-Risk Smoldering Myeloma

Omar Nadeem, Sarah Nikiforow, Kevin DeBraganca, Anna Bosch et autres

us (code pays fourni par la source)

Feasibility, Safety and Efficacy of Oral Maintenance Therapy with Venetoclax Plus Decitabine/Cedazuridine after Venetoclax Plus FluBu2 for High Risk MDS/AML Undergoing RIC Allo-HCT

Jacqueline S. Garcia, Haesook T. Kim, Jennifer Brock, H. Moses Murdock et autres

us (code pays fourni par la source)

LBO-004 Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study

Thierry Gustot, William Bernal, Javier Fernández, Juan Manuel Díaz et autres

LBP-026 The global prospective observational study to evaluate the role of ‘liver transplantation in patients with cirrhosis and severe acuteon-chronic liver failure (CHANCE)’: study design, demographics and overall outcome

Thierry Gustot, William Bernal, Javier Fernández, Juan Manuel Díaz et autres

FRI-171 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation

María Pilar Ballester, Tobias Laue, Lilianeleny Meoli, Eva Uson et autres

Zonal expression of StARD1 and oxidative stress in alcoholic-related liver disease

Raquel Fucho, Estel Solsona‐Vilarrasa, Sandra Torres, Susana Núñez et autres

es, us (code pays fourni par la source)

Characterization of microglia behaviour in healthy and pathological conditions with image analysis tools

Aleix M. Martı́nez, Jean-Karim Hèriché, Marı́a Calvo, Christian Tischer et autres

es, de (code pays fourni par la source)